FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Oystein Fodstad

Research Profile

Anatomy

Living Beings

Disorders

Procedures

Chemicals & Drugs

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Shruti Desai; Oystein Fodstad; Zixing Liu; Nishant Patel; Erin Eun-Young Ahn; Jieqing Chen; Yun Wu; Jun Yao; Ming Tan
Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7).
Zixing Liu; Steven McClellan; David C Schmitt; Shruti Desai; Oystein Fodstad; Hung T Khong; Kristine S Klos; Hao Liu; Ming Zhou; Ming Tan
miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.
Vibeke Anett Ingebrigtsen; Jahn Martin Nesland; Christina Tekle; Kjetil Boye; Kjersti Flatmark; Oystein Fodstad
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Oystein Fodstad (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Shruti Desai; Oystein Fodstad; Zixing Liu; Nishant Patel; Erin Eun-Young Ahn; Jieqing Chen; Yun Wu; Jun Yao; Ming Tan
Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7).
The Journal of biological chemistry 2013;288(13):9165-76.
2013: Zixing Liu; Steven McClellan; David C Schmitt; Shruti Desai; Oystein Fodstad; Hung T Khong; Kristine S Klos; Hao Liu; Ming Zhou; Ming Tan
miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.
The Journal of biological chemistry 2013;288(6):4334-45.
2012: Vibeke Anett Ingebrigtsen; Jahn Martin Nesland; Christina Tekle; Kjetil Boye; Kjersti Flatmark; Oystein Fodstad
B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
International journal of cancer. Journal international du cancer 2012;131(11):2528-36.
2012: Andrew J Vincent; Daniel J Devine; Oystein Fodstad; Lillianne G Harris; Suping Ren; Rajeev S Samant; Lalita A Shevde
Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance.
FEBS letters 2012;586(19):3429-34.
2012: Christina Tekle; Yih-Wen Chen; Indrejit Dybsjord; Gunhild M Maelandsmo; Jahn Marthin Nesland; Marit Kveine Nygren; Oystein Fodstad
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.
International journal of cancer. Journal international du cancer 2012;130(10):2282-90.
2012: Yan Ding; Oystein Fodstad; Susan P LeDoux; Hao Liu; Zixing Liu; Jianrong Lu; Laurie B Owen; Lewis K Pannell; Glenn L Wilson; Elizabeth R Wright; Hong Yi; Yuhua Zhao; Windy Dean-Colomb; Shruti Desai; Ming Tan
Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism.
Nature communications 2012;3():1271.
2012: Kristina Schee; Oystein Fodstad; Torveig Weum Abrahamsen; Kjetil Boye; Kjersti Flatmark
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer.
BMC cancer 2012;12():505.
2011: Marie Grøn Saelen; Rik de Wijn; Kjersti Flatmark; Oystein Fodstad; Sigurd Folkvord; Heidi Rasmussen; Anne Hansen Ree
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.
Angiogenesis 2011;14(4):481-9.
2011: Skjalg Bruheim; Alexandr Kristian; Toshimitsu Uenaka; Zhenhe Suo; Akihiko Tsuruoka; Jahn M Nesland; Oystein Fodstad
Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts.
International journal of cancer. Journal international du cancer 2011;129(3):742-50.
2011: Yuhua Zhao; Richard Voellmy; Glenn L Wilson; Yun Wu; Jieqing Chen; Yan Ding; Oystein Fodstad; Susan P LeDoux; Wensheng Lin; Yifeng Lin; Bolin Liu; Hao Liu; Zixing Liu; Rita Nahta; Janet E Price; Ming Tan
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.
Cancer research 2011;71(13):4585-97.
2011: Hao Liu; Zixing Liu; Gunhild Mari Mælandsmo; Jahn Marthin Nesland; Yih-Wen Chen; Yan Ding; Oystein Fodstad; Alexandr Kristian; Christina Tekle; Bin Wang; Yuhua Zhao; Ming Zhou; Ming Tan
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
Molecular cancer therapeutics 2011;10(6):960-71.
2011: André Bergman; Auke D Adema; Jan Balzarini; Skjalg Bruheim; Iduna Fichtner; Paul Noordhuis; Oystein Fodstad; F Myhren; ML Sandvold; HR Hendriks; Godefridus J Peters
Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Investigational new drugs 2011;29(3):456-66.
2011: Geir Olav Hjortland; Hanne Hoifodt; Knut H Hole; Leonardo A. Meza-Zepeda; Ola Myklebost; Anne Hansen Ree; Sigbjørn Smeland; Siri Tveito; Klaus Beiske; Per J Bohler; Oystein Fodstad; Eivind Hovig
Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
BMC cancer 2011;11():455.
2011: Karianne Risberg; Oystein Fodstad; Yvonne Andersson
Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.
PloS one 2011;6(9):e24012.
2011: Siri Tveito; Kristin Andersen; Rolf Kåresen; Oystein Fodstad
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
Breast cancer research : BCR 2011;13(4):R75.
2011: Marit Kveine Nygren; Christina Tekle; Vibeke Anett Ingebrigtsen; Oystein Fodstad
B7-H3 and its relevance in cancer; immunological and non-immunological perspectives.
Frontiers in bioscience (Elite edition) 2011;3():989-93.
2011: Bin Wang; Paul Howel; Skjalg Bruheim; Jingfang Ju; Laurie B Owen; Oystein Fodstad; Yaguang Xi
Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array.
PloS one 2011;6(2):e17167.
2011: Yuhua Zhao; Hao Liu; Adam I Riker; Oystein Fodstad; Susan P LeDoux; Glenn L Wilson; Ming Tan
Emerging metabolic targets in cancer therapy.
Frontiers in bioscience : a journal and virtual library 2011;16():1844-60.
2010: Suping Ren; Suhu Liu; Paul M Howell; Guangyu Zhang; Lewis Pannell; Rajeev S Samant; Lalita Shevde-Samant; J Allan Tucker; Oystein Fodstad; Adam I Riker
Functional characterization of the progestagen-associated endometrial protein gene in human melanoma.
Journal of cellular and molecular medicine 2010;14(6B):1432-42.
2010: Karianne Risberg; Oystein Fodstad; Yvonne Andersson
Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010;33(3):272-8.
2010: Javier Mercapide; Germana Rappa; Fabio Anzanello; Judy King; Oystein Fodstad; Aurelio Lorico
Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma.
International journal of cancer. Journal international du cancer 2010;126(5):1206-15.
2010: Karianne Risberg; Oystein Fodstad; Yvonne Andersson
Immunotoxins: a promising treatment modality for metastatic melanoma?
The Ochsner journal 2010;10(3):193-9.
2010: Brandon J Metge; Suhu Liu; Adam I Riker; Oystein Fodstad; Rajeev S Samant; Lalita A Shevde
Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1.
Oncology 2010;78(1):75-86.
2010: Ming Zhou; Yuhua Zhao; Yan Ding; Hao Liu; Zixing Liu; Oystein Fodstad; Adam I Riker; Sushama Kamarajugadda; Jianrong Lu; Laurie B Owen; Susan P LeDoux; Ming Tan
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol.
Molecular cancer 2010;9():33.
2009: Skjalg Bruheim; Yaguang Xi; Jingfang Ju; Oystein Fodstad
Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7161-9.
2009: Anna Bergamaschi; Geir Olav Hjortland; Tiziana Triulzi; Therese Sørlie; Hilde Johnsen; Anne Hansen Ree; Hege Giercksky Russnes; Sigurd Tronnes; Gunhild M Maelandsmo; Oystein Fodstad; Anne-Lise Borresen-Dale; Olav Engebraaten
Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
Molecular oncology 2009;3(5-6):469-82.
2009: Uttio Roy Chowdhury; Rajeev S Samant; Oystein Fodstad; Lalita A Shevde
Emerging role of nuclear protein 1 (NUPR1) in cancer biology.
Cancer metastasis reviews 2009;28(1-2):225-32.
2008: Suhu Liu; Suping Ren; Paul Howell; Oystein Fodstad; Adam I Riker
Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Pigment cell & melanoma research 2008;21(5):545-58.
2008: Aurelio Lorico; Javier Mercapide; V Solodushko; V Soloduschko; M Alexeyev; Oystein Fodstad; G Rappa
Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma.
Cancer gene therapy 2008;15(9):605-15.
2008: David W Clark; Aparna Mitra; Rebecca A Fillmore; Wen Jiang; Rajeev S Samant; Oystein Fodstad; Lalita A Shevde
NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
Current cancer drug targets 2008;8(5):421-30.
2008: Yih-Wen Chen; Christina Tekle; Oystein Fodstad
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.
Current cancer drug targets 2008;8(5):404-13.
2008: Paal Fr Brunsvig; Kjersti Flatmark; Steinar Aamdal; Hanne Høifødt; Hang Le; Erling Jakobsen; Berit Sandstad; Oystein Fodstad
Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients.
Lung cancer (Amsterdam, Netherlands) 2008;61(2):170-6.
2008: Germana Rappa; Javier Mercapide; Fabio Anzanello; Lina Prasmickaite; Yaguang Xi; Jingfang Ju; Oystein Fodstad; Aurelio Lorico
Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets.
Experimental cell research 2008;314(10):2110-22.
2008: Adam I Riker; Steven A Enkemann; Oystein Fodstad; Suhu Liu; Suping Ren; Christopher Morris; Yaguang Xi; Paul Howell; Brandon J Metge; Rajeev S Samant; Lalita A Shevde; Wenbin Li; Steven Eschrich; Adil Daud; Jingfang Ju; Jaime Matta
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis.
BMC medical genomics 2008;1():13.
2008: Go Nakajima; Ana Patino-Garcia; Skjalg Bruheim; Yaguang Xi; Mikel San-Julian; Fernando Lecanda; Luis Sierrasesumaga; Christoph Müller; Oystein Fodstad; Jingfang Ju
CDH11 expression is associated with survival in patients with osteosarcoma.
Cancer genomics & proteomics 2008;5(1):37-42.
2008: Yaguang Xi; Adam Riker; Lalita Shevde-Samant; Rajeev Samant; Christopher Morris; Elaine Gavin; Oystein Fodstad; Jingfang Ju
Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.
Cancer genomics & proteomics 2008;5(1):1-35.
2007: Natalie N Bauer; Yih-Wen Chen; Rajeev S Samant; Lalita A Shevde; Oystein Fodstad
Rac1 activity regulates proliferation of aggressive metastatic melanoma.
Experimental cell research 2007;313(18):3832-9.
2007: Trine Lillehammer; Birgit O Engesaeter; Lina Prasmickaite; Gunhild M Maelandsmo; Oystein Fodstad; Olav Engebraaten
Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
The journal of gene medicine 2007;9(6):440-51.
2007: Germana Rappa; Fabio Anzanello; Mikhail Alexeyev; Oystein Fodstad; Aurelio Lorico
Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease.
European journal of haematology 2007;78(5):440-8.
2007: Siri Tveito; Gunhild M Maelandsmo; Hanne K Hoifodt; Heidi Rasmussen; Oystein Fodstad
Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value.
Clinical & experimental metastasis 2007;24(5):317-27.
2006: Yaguang Xi; Go Nakajima; Tray Hamil; Oystein Fodstad; Adam I Riker; Jingfang Ju
Association of insulin-like growth factor binding protein-3 expression with melanoma progression.
Molecular cancer therapeutics 2006;5(12):3078-84.
2006: Anne Hansen Ree; Trond Stokke; Ase Bratland; Sebastian Patzke; Ragnhild V Nome; Sigurd Folkvord; Leonardo A. Meza-Zepeda; Kjersti Flatmark; Oystein Fodstad; Yvonne Andersson
DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting.
Anticancer research 2006;26(3A):1909-16.
2006: Flaubert Mbeunkui; Oystein Fodstad; Lewis K Pannell
Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.
Journal of proteome research 2006;5(4):899-906.
2005: Trine Lillehammer; Siri Tveito; Birgit O Engesaeter; Oystein Fodstad; Gunhild M Maelandsmo; Olav Engebraaten
Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Cancer gene therapy 2005;12(11):864-72.
2005: Ragnhild V Nome; Ase Bratland; Gunhild Harman; Oystein Fodstad; Yvonne Andersson; Anne Hansen Ree
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.
Molecular cancer therapeutics 2005;4(8):1231-8.
2005: Kristin Bjørnland; Kjersti Flatmark; Solveig Pettersen; Ansgar O Aaasen; Oystein Fodstad; Gunhild M Maelandsmo
Matrix metalloproteinases participate in osteosarcoma invasion.
The Journal of surgical research 2005;127(2):151-6.
2005: Oyvind S Bruland; Hanne K Høifødt; Gunnar Saeter; Sigbjørn Smeland; Oystein Fodstad
Hematogenous micrometastases in osteosarcoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13):4666-73.
2005: Aurelio Lorico; Daniel Bratbak; Johann Meyer; David Kunke; Stefan Krauss; Walter E Plott; Viktoriya Solodushko; Christopher Baum; Oystein Fodstad; Germana Rappa
Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells.
Human gene therapy 2005;16(6):711-24.
2004: Anne Hansen Ree; Ase Bratland; Ragnhild V Nome; Trond Stokke; Oystein Fodstad; Yvonne Andersson
Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;72(3):305-10.
2004: Anne Hansen Ree; Ase Bratland; Kirsti Solberg Landsverk; Oystein Fodstad
Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner.
Anticancer research 2004;24(2B):555-62.
2004: Geir Olav Hjortland; solveig garman-vik; Siri Juell; Oyvind Edon Olsen; Henry Hirschberg; Oystein Fodstad; Olav Engebraaten
Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
Journal of neurosurgery 2004;100(2):320-7.
2004: Skjalg Bruheim; Oyvind S Bruland; Knut Breistol; Gunhild M Maelandsmo; Oystein Fodstad
Human osteosarcoma xenografts and their sensitivity to chemotherapy.
Pathology oncology research : POR 2004;10(3):133-41.
2004: Judy A King; Solomon F Ofori-Acquah; Troy Stevens; Abu-Bakr Al-Mehdi; Oystein Fodstad; Wen Jiang
Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator.
Breast cancer research : BCR 2004;6(5):R478-87.
2004: Germana Rappa; David Kunke; J Holter; Dzung B Diep; J Meyer; Christopher Baum; Oystein Fodstad; Stefan Krauss; Aurelio Lorico
Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin.
Neuroscience 2004;124(4):823-30.
2003: Kristin Bjørnland; Kjersti Flatmark; Tom Mala; Oystein Mathisen; Arne Bakka; Ansgar O Aasen; Anstein Bergan; Odd Søreide; Oystein Fodstad
Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer.
Journal of surgical oncology 2003;82(4):224-7.
2003: Berit Mathisen; Rune I Lindstad; Janne Hansen; Sara Ann El-Gewely; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells.
Clinical & experimental metastasis 2003;20(8):701-11.
2003: Ase Bratland; Erlend Ragnhildstveit; Kristin Bjørnland; Kristin Andersen; Gunhild M Maelandsmo; Oystein Fodstad; Fahri Saatcioglu; Anne Hansen Ree
The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Clinical & experimental metastasis 2003;20(6):541-7.
2003: Geir Olav Hjortland; Kristin Bjørnland; Solveig Pettersen; solveig garman-vik; Elisabeth Emilsen; Jahn M Nesland; Oystein Fodstad; Olav Engebraaten
Modulation of glioma cell invasion and motility by adenoviral gene transfer of PAI-1.
Clinical & experimental metastasis 2003;20(4):301-9.
2003: Germana Rappa; M P Gamcsik; R L Mitina; Christopher Baum; Oystein Fodstad; Aurelio Lorico
Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy.
European journal of cancer (Oxford, England : 1990) 2003;39(1):120-8.
2002: Anne Hansen Ree; Ase Bratland; Roger Kroes; Hans-Christian Aasheim; Vivi Ann Flørenes; Joseph R Moskal; Oystein Fodstad; Oyvind S Bruland; Gunhild M Maelandsmo
Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases.
Anticancer research 2002;22(4):1949-57.
2002: Anders Høgset; Birgit O Engesaeter; Lina Prasmickaite; Kristian Berg; Oystein Fodstad; Gunhild M Maelandsmo
Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy.
Cancer gene therapy 2002;9(4):365-71.
2002: Aurelio Lorico; Antonella Bertola; Christopher Baum; Oystein Fodstad; Germana Rappa
Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice.
Biochemical and biophysical research communications 2002;291(3):617-22.
2002: Aurelio Lorico; Jahn Nesland; Elisabeth Emilsen; Oystein Fodstad; Germana Rappa
Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice.
Toxicology 2002;171(2-3):201-5.
2002: Olav Engebraaten; Geir Olav Hjortland; Siri Juell; Henry Hirschberg; Oystein Fodstad
Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals.
International journal of cancer. Journal international du cancer 2002;97(6):846-52.
2001: Pål Kristian Selbo; G Sivam; Oystein Fodstad; Kirsten Sandvig; Kristian Berg
In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy.
International journal of cancer. Journal international du cancer 2001;92(5):761-6.
2001: Eivind Hovig; Gunhild M Maelandsmo; T Mellingsaeter; Oystein Fodstad; S S Mielewczyk; J Wolfe; J Goodchild
Optimization of hammerhead ribozymes for the cleavage of S100A4 (CAPL) mRNA.
Antisense & nucleic acid drug development 2001;11(2):67-75.
2001: Oystein Fodstad; Ragnar S Faye; Hanne K Høifødt; Eva Skovlund; Steinar Aamdal
Immunobead-based detection and characterization of circulating tumor cells in melanoma patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():40-50.
2000: Olav Engebraaten; G Sivam; Siri Juell; Oystein Fodstad
Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats.
International journal of cancer. Journal international du cancer 2000;88(6):970-6.
2000: Ase Bratland; Karianne Risberg; Gunhild M Maelandsmo; Kristine Bjerve Gützkow; O E Olsen; A Moghaddam; M Y Wang; C M Hansen; Heidi Kiil Blomhoff; Jens Berg; Oystein Fodstad; Anne Hansen Ree
Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.
Cancer research 2000;60(19):5578-83.
2000: Pål Kristian Selbo; G Sivam; Oystein Fodstad; Kirsten Sandvig; Kristian Berg
Photochemical internalisation increases the cytotoxic effect of the immunotoxin MOC31-gelonin.
International journal of cancer. Journal international du cancer 2000;87(6):853-9.
2000: Anne Hansen Ree; Mercia Medeiros Pacheco; M Tvermyr; Oystein Fodstad; Maria Mitzi Brentani
Expression of a novel factor, com1, in early tumor progression of breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1778-83.
2000: Germana Rappa; Krishnamurthy Shyam; Aurelio Lorico; Oystein Fodstad; Alan C Sartorelli
Structure-activity studies of novobiocin analogs as modulators of the cytotoxicity of etoposide (VP-16).
Oncology research 2000;12(3):113-9.
1999: Kristin Bjørnland; Jan-Olof Winberg; O T Odegaard; Eivind Hovig; Thrina Loennechen; Ansgar O Aasen; Oystein Fodstad; Gunhild M Maelandsmo
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
Cancer research 1999;59(18):4702-8.
1999: Anne Hansen Ree; M Tvermyr; Olav Engebraaten; M Rooman; Oystein Røsok; Eivind Hovig; Leonardo A. Meza-Zepeda; Oyvind S Bruland; Oystein Fodstad
Expression of a novel factor in human breast cancer cells with metastatic potential.
Cancer research 1999;59(18):4675-80.
1999: Olav Engebraaten; Oystein Fodstad
Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats.
International journal of cancer. Journal international du cancer 1999;82(2):219-25.
1999: K Breistøl; HR Hendriks; Oystein Fodstad
Superior therapeutic efficacy of N-L-leucyl-doxorubicin versus doxorubicin in human melanoma xenografts correlates with higher tumour concentrations of free drug.
European journal of cancer (Oxford, England : 1990) 1999;35(7):1143-9.
1999: K Breistøl; Jan Balzarini; ML Sandvold; F Myhren; M Martinsen; Erik De Clercq; Oystein Fodstad
Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
Cancer research 1999;59(12):2944-9.
1999: Anne Forus; Hanne K Høifødt; G E Overli; Ola Myklebost; Oystein Fodstad
Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.
Molecular pathology : MP 1999;52(2):68-74.
1999: Kristian Berg; Pål Kristian Selbo; Lina Prasmickaite; Torunn E Tjelle; Kirsten Sandvig; Johan Moan; Gustav Gaudernack; Oystein Fodstad; S Kjølsrud; H Anholt; GH Rodal; SK Rodal; Anders Høgset
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.
Cancer research 1999;59(6):1180-3.
1999: P Ruud; Oystein Fodstad; Eivind Hovig
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
International journal of cancer. Journal international du cancer 1999;80(1):119-25.
1999: Elin Borgen; Bjørn Naume; Jahn M Nesland; Gunnar Kvalheim; K Beiske; Oystein Fodstad; I Diel; Erich Solomayer; P Theocharous; R C Coombes; B M Smith; E Wunder; J P Marolleau; J Garcia; Klaus Pantel
Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.
Cytotherapy 1999;1(5):377-88.
1999: Olav Engebraaten; Geir Olav Hjortland; Henry Hirschberg; Oystein Fodstad
Growth of precultured human glioma specimens in nude rat brain.
Journal of neurosurgery 1999;90(1):125-32.
1998: Lina Prasmickaite; A Hogset; Gunhild M Maelandsmo; Kristian Berg; J Goodchild; T Perkins; Oystein Fodstad; Eivind Hovig
Intracellular metabolism of a 2'-O-methyl-stabilized ribozyme after uptake by DOTAP transfection or asfree ribozyme. A study by capillary electrophoresis.
Nucleic acids research 1998;26(18):4241-8.
1998: K Breistøl; HR Hendriks; Dietmar P Berger; S P Langdon; Heinz-Herbert Fiebig; Oystein Fodstad
The antitumour activity of the prodrug N-L-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 1998;34(10):1602-6.
1998: K Andersen; Gunhild M Maelandsmo; Eivind Hovig; Oystein Fodstad; Thrina Loennechen; Jan-Olof Winberg
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPL.
Anticancer research 1998;18(5A):3299-303.
1998: Anne Forus; Jeanne-Marie Berner; Leonardo A. Meza-Zepeda; Gunnar Saeter; Dietmar Mischke; Oystein Fodstad; Ola Myklebost
Molecular characterization of a novel amplicon at 1q21-q22 frequently observed in human sarcomas.
British journal of cancer 1998;78(4):495-503.
1998: Anne Hansen Ree; Kristin Bjørnland; N Brünner; HT Johansen; Kjetil Boye Pedersen; Ansgar O Aasen; Oystein Fodstad
Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
Clinical & experimental metastasis 1998;16(3):205-15.
1998: Phil D Rye; Oystein Fodstad; Elisabeth Emilsen; Magne Bryne
Invasion potential and N-acetylgalactosamine expression in a human melanoma model.
International journal of cancer. Journal international du cancer 1998;75(4):609-14.
1998: Kristin Bjørnland; Gustav Lehne; HT Johansen; Oystein Fodstad; Hans Erik Rugstad; Ansgar O Aasen; Anne Hansen Ree
Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells.
Oncology research 1998;10(5):255-62.
1997: Anne Hansen Ree; V A Florenes; Jens Berg; Gunhild M Maelandsmo; J M Nesland; Oystein Fodstad
High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1623-8.
1997: Gunhild M Maelandsmo; Vivi Ann Flørenes; T Mellingsaeter; Eivind Hovig; R S Kerbel; Oystein Fodstad
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma.
International journal of cancer. Journal international du cancer 1997;74(4):464-9.
1997: H de Graaf; Gunhild M Maelandsmo; P Ruud; Anne Forus; T Oyjord; Oystein Fodstad; Eivind Hovig
Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2.
International journal of cancer. Journal international du cancer 1997;72(1):191-6.
1997: Jeanne-Marie Berner; Leonardo A. Meza-Zepeda; P F Kools; Anne Forus; E F Schoenmakers; W J Van de Ven; Oystein Fodstad; Ola Myklebost
HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.
Oncogene 1997;14(24):2935-41.
1997: KA Semb; Oystein Fodstad; B Klem; K Bibow; K Osmundsen; Steinar Aamdal
Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation.
Anti-cancer drugs 1997;8(3):296-303.
1997: Phil D Rye; Hanne K Høifødt; G E Overli; Oystein Fodstad
Immunobead filtration: a novel approach for the isolation and propagation of tumor cells.
The American journal of pathology 1997;150(1):99-106.
1996: Gunhild M Maelandsmo; Eivind Hovig; Martina Skrede; Olav Engebraaten; Vivi Ann Flørenes; Ola Myklebost; Mariam Grigorian; Eugene Lukanidin; K J Scanlon; Oystein Fodstad
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.
Cancer research 1996;56(23):5490-8.
1996: Gunhild M Maelandsmo; Ruth Holm; Oystein Fodstad; Robert S Kerbel; Vivi Ann Flørenes
Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.
The American journal of pathology 1996;149(6):1813-22.
1996: Jeanne-Marie Berner; Anne Forus; Abdel G Elkahloun; Paul S Meltzer; Oystein Fodstad; Ola Myklebost
Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
Genes, chromosomes & cancer 1996;17(4):254-9.
1996: Phil D Rye; L Norum; Dag Rune Olsen; S Garman-Vik; S Kaul; Oystein Fodstad
Brain metastasis model in athymic nude mice using a novel MUC1-secreting human breast-cancer cell line, MA11.
International journal of cancer. Journal international du cancer 1996;68(5):682-7.
1996: Anne Hansen Ree; Gunhild M Maelandsmo; Oystein Fodstad
Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.
Clinical & experimental metastasis 1996;14(4):381-8.
1996: Gunnar Kvalheim; M Y Wang; A Pharo; Harald Holte; E Jacobsen; K Beiske; Stein Kvaløy; Erlend Smeland; Steinar Funderud; Oystein Fodstad
Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
Journal of hematotherapy 1996;5(4):427-36.
1996: Kristin Bjørnland; L Buø; I Kjønniksen; M Larsen; Oystein Fodstad; HT Johansen; Ansgar O Aasen
Cysteine proteinase inhibitors reduce malignant melanoma cell invasion in vitro.
Anticancer research 1996;16(4A):1627-31.
1996: Gunhild M Maelandsmo; Vivi Ann Flørenes; Eivind Hovig; T Oyjord; Olav Engebraaten; Ruth Holm; A L Børresen; Oystein Fodstad
Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
British journal of cancer 1996;73(8):909-16.
1996: Oystein Fodstad; K Breistøl; George R Pettit; R H Shoemaker; M R Boyd
Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.
Journal of experimental therapeutics & oncology 1996;1(2):119-25.
1995: Phil D Rye; Nicolai V Bovin; E Vlasova; Hanne K Høifødt; B Kierulf; G E Trones; Oystein Fodstad
Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.
Biochemical Society transactions 1995;23(4):584S.
1995: Anne Forus; D O Weghuis; Dominique Smeets; Oystein Fodstad; Ola Myklebost; A G van Kessel
Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas.
Genes, chromosomes & cancer 1995;14(1):8-14.
1995: Anne Forus; D O Weghuis; Dominique Smeets; Oystein Fodstad; Ola Myklebost; Ad Geurts van Kessel
Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcomas.
Genes, chromosomes & cancer 1995;14(1):15-21.
1995: Gunhild M Maelandsmo; Jeanne-Marie Berner; Vivi Ann Flørenes; Anne Forus; Eivind Hovig; Oystein Fodstad; Ola Myklebost
Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
British journal of cancer 1995;72(2):393-8.
1995: D Y Wen; Walter A Hall; J Conrad; A Godal; V A Flørenes; Oystein Fodstad
In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Neurosurgery 1995;36(6):1158-63; discussion 1163-4.
1995: Vivi Ann Flørenes; Ruth Holm; Oystein Fodstad
Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome.
Melanoma research 1995;5(3):183-7.
1995: A Helseth; E Haug; Jahn M Nesland; G P Siegal; Oystein Fodstad; Victoria L Bautch
Endocrine and metabolic characteristics of polyoma large T transgenic mice that develop ACTH-producing pituitary tumors.
Journal of neurosurgery 1995;82(5):879-85.
1995: A H Deggerdal; F Pettersen; Gunnar Kvalheim; E Hornes; Erlend Smeland; Oystein Fodstad; Eivind Hovig
Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Laboratory investigation; a journal of technical methods and pathology 1995;72(4):411-8.
1995: Mette Winderen; I Kjønniksen; Oystein Fodstad
Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model.
Journal of the National Cancer Institute 1995;87(3):221-2.
1994: Anne Forus; Vivi Ann Flørenes; Gunhild M Maelandsmo; Oystein Fodstad; Ola Myklebost
The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.
Cancer genetics and cytogenetics 1994;78(2):165-71.
1994: L Buø; Kristin Bjørnland; T S Karlsrud; D Kvale; I Kjønniksen; Oystein Fodstad; P Brandtzaeg; HT Johansen; Ansgar O Aasen
Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Anticancer research 1994;14(6B):2445-51.
1994: Vivi Ann Flørenes; Gunhild M Maelandsmo; Anne Forus; A Andreassen; Ola Myklebost; Oystein Fodstad
MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.
Journal of the National Cancer Institute 1994;86(17):1297-302.
1994: Oystein Fodstad; I Kjønniksen
Microenvironment revisited: time for reappraisal of some prevailing concepts of cancer metastasis.
Journal of cellular biochemistry 1994;56(1):23-8.
1994: I Kjønniksen; P D Rye; Oystein Fodstad
Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.
British journal of cancer 1994;69(6):1021-4.
1994: Simon P Langdon; HR Hendriks; Boudewijn J M Braakhuis; G Pratesi; Dietmar P Berger; Oystein Fodstad; Heinz-Herbert Fiebig; Epie Boven
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(5):415-22.
1994: A T Myklebust; A Godal; Oystein Fodstad
Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.
Cancer research 1994;54(8):2146-50.
1994: I Kjønniksen; Mette Winderen; Oyvind S Bruland; Oystein Fodstad
Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats.
Cancer research 1994;54(7):1715-9.
1994: Walter A Hall; A Myklebust; A Godal; Jahn M Nesland; Oystein Fodstad
In vivo efficacy of intrathecal transferrin-Pseudomonas exotoxin A immunotoxin against LOX melanoma.
Neurosurgery 1994;34(4):649-55; discussion 655-6.
1994: Vivi Ann Flørenes; T Oyjord; Ruth Holm; Martina Skrede; A L Børresen; Jahn M Nesland; Oystein Fodstad
TP53 allele loss, mutations and expression in malignant melanoma.
British journal of cancer 1994;69(2):253-9.
1994: Vivi Ann Flørenes; Ruth Holm; Ola Myklebost; U Lendahl; Oystein Fodstad
Expression of the neuroectodermal intermediate filament nestin in human melanomas.
Cancer research 1994;54(2):354-6.
1994: Oyvind S Bruland; Oystein Fodstad; Magne Aas; OP Solheim; J Høie; Arne Skretting; Mette Winderen; T Michaelsen; A Pihl
Immunoscintigraphy of bone sarcomas--results in 5 patients.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1484-9.
1994: Gunnar Kvalheim; E Jakobsen; Harald Holte; K Beiske; Ruth Langholm; A Høiby; M Y Wang; S Funderund; Oystein Fodstad; Erlend Smeland
Autologous bone marrow transplantation of non-Hodgkin's lymphoma patients with marrow purged using immunomagnetic beads.
Progress in clinical and biological research 1994;389():133-8.
1994: M Y Wang; Oystein Fodstad; Steinar Funderud; M Bengtsson; T Totterman; W D Ludwig; H Martin; Gunnar Kvalheim
A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment.
Progress in clinical and biological research 1994;389():119-24.
1994: A T Myklebust; A Helseth; K Breistøl; Walter A Hall; Oystein Fodstad
Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs.
Journal of neuro-oncology 1994;21(3):215-24.
1994: A T Myklebust; A Godal; S Juell; A Pharo; Oystein Fodstad
Comparison of two antibody-based methods for elimination of breast cancer cells from human bone marrow.
Cancer research 1994;54(1):209-14.
1993: Anne Forus; Vivi Ann Flørenes; Gunhild M Maelandsmo; Paul S Meltzer; Oystein Fodstad; Ola Myklebost
Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(12):1065-70.
1993: D Y Wen; Walter A Hall; Oystein Fodstad
Rapid detection of transferrin receptor expression on glioma cell lines by using magnetic microspheres.
Neurosurgery 1993;33(5):878-81.
1993: A T Myklebust; A Godal; A Pharo; S Juell; Oystein Fodstad
Eradication of small cell lung cancer cells from human bone marrow with immunotoxins.
Cancer research 1993;53(16):3784-8.
1993: A T Myklebust; A Pharo; Oystein Fodstad
Effective removal of SCLC cells from human bone marrow. Use of four monoclonal antibodies and immunomagnetic beads.
British journal of cancer 1993;67(6):1331-6.
1993: A Helseth; Victoria L Bautch; E Haug; R Holm; Jahn M Nesland; Oystein Fodstad
[Transgenic mice as animal model of Cushing's syndrome].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(2):206-10.
1992: HR Hendriks; J Plowman; Dietmar P Berger; K D Paull; Heinz-Herbert Fiebig; Oystein Fodstad; H C Dreef-van der Meulen; R E Henrar; HERBERT PINEDO; G Schwartsmann
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):755-63.
1992: Epie Boven; B Winograd; Dietmar P Berger; M P Dumont; Boudewijn J M Braakhuis; Oystein Fodstad; Simon P Langdon; Heinz-Herbert Fiebig
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.
Cancer research 1992;52(21):5940-7.
1992: Vivi Ann Flørenes; Steinar Aamdal; Ola Myklebost; Gunhild M Maelandsmo; Oyvind S Bruland; Oystein Fodstad
Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.
Cancer research 1992;52(21):6088-91.
1992: A Godal; B Kumle; A Pihl; S Juell; Oystein Fodstad
Immunotoxins directed against the high-molecular-weight melanoma-associated antigen. Identification of potent antibody-toxin combinations.
International journal of cancer. Journal international du cancer 1992;52(4):631-5.
1992: K Beiske; A T Myklebust; S Aamdal; Ruth Langholm; E Jakobsen; Oystein Fodstad
Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods.
The American journal of pathology 1992;141(3):531-8.
1992: M Y Wang; Gunnar Kvalheim; Stein Kvaløy; K Beiske; E Jakobsen; J Wijdenes; A Pihl; Oystein Fodstad
An effective immunomagnetic method for bone marrow purging in T cell malignancies.
Bone marrow transplantation 1992;9(5):319-23.
1992: Walter A Hall; A Godal; S Juell; Oystein Fodstad
In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme.
Journal of neurosurgery 1992;76(5):838-44.
1992: I Kjønniksen; K Breistøl; Oystein Fodstad
Site-dependent differences in sensitivity of LOX human melanoma tumors in nude rats to dacarbazine and mitozolomide, but not to doxorubicin and cisplatin.
Cancer research 1992;52(5):1347-51.
1992: Walter A Hall; Oystein Fodstad
Immunotoxins and central nervous system neoplasia.
Journal of neurosurgery 1992;76(1):1-12.
1992: HR Hendriks; Simon P Langdon; Dietmar P Berger; K Breistøl; Heinz-Herbert Fiebig; Oystein Fodstad; G Schwartsmann
Comparative antitumour activity of vinblastine-isoleucinate and related vinca alkaloids in human tumour xenografts.
European journal of cancer (Oxford, England : 1990) 1992;28A(4-5):767-73.
1991: Eivind Hovig; Ragnhild A Lothe; G Farrants; A Brøgger; Oystein Fodstad; A L Børresen
Chromosome 13 alterations in osteosarcoma cell lines derived from a patient with previous retinoblastoma.
Cancer genetics and cytogenetics 1991;57(1):31-40.
1991: I Kjønniksen; Hanne K Høifødt; A Pihl; Oystein Fodstad
Different metastasis patterns of a human melanoma cell line in nude mice and rats: influence of microenvironment.
Journal of the National Cancer Institute 1991;83(14):1020-4.
1991: A T Myklebust; K Beiske; A Pharo; C D Davies; S Aamdal; Oystein Fodstad
Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis.
The British journal of cancer. Supplement 1991;14():49-53.
1991: R T Storeng; I Kjønniksen; A Pihl; E Haug; Oystein Fodstad
Athymic rats in preclinical immunodiagnostic studies.
Anticancer research 1991;11(2):649-55.
1990: I Kjønniksen; Jahn M Nesland; A Pihl; Oystein Fodstad
Nude rat model for studying metastasis of human tumor cells to bone and bone marrow.
Journal of the National Cancer Institute 1990;82(5):408-12.
1989: I Kjønniksen; R Storeng; A Pihl; T L McLemore; Oystein Fodstad
A human tumor lung metastasis model in athymic nude rats.
Cancer research 1989;49(18):5148-52.
1989: Gunnar Kvalheim; J G Fjeld; A Pihl; Steinar Funderud; J Ugelstad; Oystein Fodstad; Kjell Nustad
Immunomagnetic removal of B-lymphoma cells using a novel mono-sized magnetizable polymer bead, M-280, in conjunction with primary IgM and IgG antibodies.
Bone marrow transplantation 1989;4(5):567-74.
1988: Gunnar Kvalheim; Steinar Funderud; Stein Kvaløy; G Gaudernack; K Beiske; E Jakobsen; A B Jacobsen; A Pihl; Oystein Fodstad
Successful clinical use of an anti-HLA-DR monoclonal antibody for autologous bone marrow transplantation.
Journal of the National Cancer Institute 1988;80(16):1322-5.
1988: A Godal; Oystein Fodstad; A Pihl
Kinetics of uptake and degradation of an abrin immunotoxin by melanoma cells and studies of the rates of cellular intoxication.
International journal of cancer. Journal international du cancer 1988;42(3):400-4.
1988: Oyvind S Bruland; Oystein Fodstad; A E Stenwig; A Pihl
Expression and characteristics of a novel human osteosarcoma-associated cell surface antigen.
Cancer research 1988;48(18):5302-9.
1988: Oystein Fodstad; I Kjønniksen; Steinar Aamdal; Jahn M Nesland; M R Boyd; A Pihl
Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Cancer research 1988;48(15):4382-8.
1988: Oystein Fodstad; Gunnar Kvalheim; A Pihl; A Godal; Steinar Funderud
New indirect approach to the therapeutic use of immunotoxins.
Journal of the National Cancer Institute 1988;80(6):439-43.
1988: Oystein Fodstad; Steinar Aamdal; M McMenamin; Jahn M Nesland; A Pihl
A new experimental metastasis model in athymic nude mice, the human malignant melanoma LOX.
International journal of cancer. Journal international du cancer 1988;41(3):442-9.
1988: Steinar Aamdal; Oystein Fodstad; A Pihl
Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors.
Cancer chemotherapy and pharmacology 1988;21(2):129-33.
1988: Gunnar Kvalheim; O Sørensen; Oystein Fodstad; Steinar Funderud; S Kiesel; Bernd Dörken; Kjell Nustad; E Jakobsen; J Ugelstad; A Pihl
Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use.
Bone marrow transplantation 1988;3(1):31-41.
1987: Steinar Aamdal; Oystein Fodstad; A Pihl
Some procedures to reduce cis-platinum toxicity reduce antitumour activity.
Cancer treatment reviews 1987;14(3-4):389-95.
1987: A Godal; Oystein Fodstad; A Pihl
Studies on the mechanism of action of abrin-9.2.27 immunotoxin in human melanoma cell lines.
Cancer research 1987;47(23):6243-7.
1987: Gunnar Kvalheim; Oystein Fodstad; A Pihl; Kjell Nustad; A Pharo; J Ugelstad; Steinar Funderud
Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies.
Cancer research 1987;47(3):846-51.
1987: Eivind Hovig; Jan-Olof Winberg; Oystein Fodstad; A Brøgger; T Gedde-Dahl
Chromosome 13 instability and esterase D expression in an osteosarcoma cell line.
Cancer genetics and cytogenetics 1987;24(2):327-34.
1986: A Godal; Oystein Fodstad; A C Morgan; A Pihl
Human melanoma cell lines showing striking inherent differences in sensitivity to immunotoxins containing holotoxins.
Journal of the National Cancer Institute 1986;77(6):1247-53.
1984: Oystein Fodstad; Gunnar Kvalheim; A Godal; J Lotsberg; Steinar Aamdal; H Høst; A Pihl
Phase I study of the plant protein ricin.
Cancer research 1984;44(2):862-5.
1984: A Godal; Oystein Fodstad; K Ingebrigtsen; A Pihl
Pharmacological studies of ricin in mice and humans.
Cancer chemotherapy and pharmacology 1984;13(3):157-63.
1983: A Godal; Oystein Fodstad; A Pihl
Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice.
International journal of cancer. Journal international du cancer 1983;32(4):515-21.
1982: Kjell Magne Tveit; Oystein Fodstad; J Lotsberg; S Vaage; A Pihl
Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters.
International journal of cancer. Journal international du cancer 1982;29(5):533-8.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.